Emendo Biotherapeutics vs Spark Therapeutics
Emendo Biotherapeutics vs Spark Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Emendo Biotherapeutics is on 59/100 and Spark Therapeutics on 58/100.
Where each one leads
Emendo Biotherapeutics
Leads on none of the measures we hold for both companies.
Spark Therapeutics
- domain rating: 80/100 against 20/100
- funding raised: $82.8M against $61.0M
At a glance
| Measure | Emendo Biotherapeutics | Spark Therapeutics |
|---|---|---|
| What it is | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. |
| Category | Healthcare, Genome Editing, CRISPR, Biotech | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2015 | 2013 |
| Headquarters | Tel Aviv, Israel | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Emendo Biotherapeutics | Spark Therapeutics |
|---|---|---|
| Employees | 41 | Not published |
| Headcount growthLast 12 months | -16.1% | Not published |
| Total funding | $61.0M | $82.8M |
| Latest round | Series B | Series B |
| LinkedIn followers | 5,333 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Emendo Biotherapeutics | Spark Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 58/100 |
| Traction | 55/100 | 40/100 |
| Team | 40/100 | 90/100 |
| Search visibility | 44/100 | 13/100 |
| Quality | 68/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Emendo Biotherapeutics | Spark Therapeutics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
What users say
| Measure | Emendo Biotherapeutics | Spark Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 3 threads |
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
Emendo Biotherapeutics vs Spark Therapeutics: common questions
Which is better, Emendo Biotherapeutics or Spark Therapeutics?
On our 0-100 score Emendo Biotherapeutics rates higher (59/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Emendo Biotherapeutics and Spark Therapeutics compare on the numbers?
Spark Therapeutics leads on domain rating (80/100 against 20/100), funding raised ($82.8M against $61.0M).
What do real users say about Emendo Biotherapeutics and Spark Therapeutics?
Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.
Read the full Emendo Biotherapeutics review and pricing or the Spark Therapeutics review and pricing. You can also browse other Emendo Biotherapeutics alternatives we track.